← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #235 OF 1,000 MOST-CITED

Written procedures - establish; returned dietary supplements

FDA cited this observation 97 times across 97 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods97
BY FISCAL YEAR
FY202644
FY202545
FY20248

How FDA worded it — real examples

You did not establish written procedures for when a returned dietary supplement is received.

Nature's Rare LLC · Chatsworth, California · Foods · 2026-06-16

You did not establish written procedures for when a returned dietary supplement is received, when a returned dietary supplement must be destroyed, or otherwise suitably disposed, when a returned dietary supplement may be salvaged and for conducting an investigation of your manufacturing processes and other batches for a returned dietary supplement.

Trinity Natural Health & Pain Management,Inc. · North Miami Beach, Florida · Foods · 2026-06-11

You did not establish written procedures for when a returned dietary supplement is received.

Professional Business Associates Inc · Van Nuys, California · Foods · 2026-06-11

You did not establish written procedures for when a returned dietary supplement is received and for conducting an investigation of your manufacturing processes and other batches for a returned dietary supplement.

Healthy Land Inc. · Los Angeles, California · Foods · 2026-06-05

You did not establish written procedures for when a returned dietary supplement is received.

LNS US LLC · Houston, Texas · Foods · 2026-06-04

You did not establish written procedures for when a returned dietary supplement is received.

Nuwati Herbals, Inc · Trenton, Texas · Foods · 2026-05-28

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharmaceutical quality systemFood industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →